[Findings and Policy Recommendations] Research Survey on Socioeconomic Factors and Women’s Health (March 6, 2023)
date : 6/21/2023
Tags: Women's Health
The English version of the report has been published. (June 21, 2023)
In conjunction with Women’s Health Week (March 1-8), Health and Global Policy Institute (HGPI) released a survey report, “Research Survey on Socioeconomic Factors and Women’s Health.”
The survey results suggest that menstrual symptoms and menopausal symptoms have a significant impact on women’s social life and cause economic losses, and that there are large differences in the utilization of menstrual leave depending on company size and employment status, suggesting the need for measures, including broad labor policies.
Four Recommendations
Recommendation 1: Recognize that initiatives for women’s health are not only important from the perspective of improving sexual and reproductive health and rights for women, but they are also vital from the perspective of reducing socioeconomic losses.
Recommendation 2: In view of the fact that many women are still suffering from dysmenorrhea or menopausal symptoms and refrain from seeking medical attention despite major struggles due to those conditions, advance initiatives centered around primary care and family obstetrics and gynecology to help women receive necessary care from physicians.
Recommendation 3: Correct disparities among companies, industries, and occupations, as well as between men and women, regarding general knowledge and systems for women’s health.
Recommendation 4: Create opportunities for comprehensive sex education during school and provide guardians with opportunities to refresh their education on such subjects through parents’ classes and workplace training programs.
For details, please see the PDF linked below.
The Research Survey on Socioeconomic Factors and Women’s Health Project Team (Titles omitted; in no particular order)
Haruka Sakamoto (Senior Manager, HGPI)
Shunichiro Kurita (Manager, HGPI)
Yukiko Kawata (Senior Associate, HGPI)
Shu Suzuki (Associate, HGPI)
Sayaka Honda (Program Specialist, HGPI)
Outside experts
Miho Iida (Assistant Professor, Department of Preventive Medicine and Public Health, School of Medicine, Keio University)
Survey research collaborators (Titles omitted; in no particular order)
Shohei Okamoto (Research Fellow, Research Team for Social Participation and Community Health, Tokyo Metropolitan Institute of Gerontology)
Rei Goto (Professor, Graduate School of Business Administration, Keio University)
Shingo Kasahara (Graduate Student, Graduate School of Business Administration, Keio University)
Shuhei Nomura (Project Associate Professor, Department of Health Policy and Management, School of Medicine, Keio University)
Akifumi Eguchi (Lecturer, Center for Preventive Medical Sciences, Chiba University)
Sponsoring companies and organizations
Bayer Yakuhin, Ltd
Fuji Pharma Co., Ltd.
*While opinion exchanges were held with supporting companies and organizations when conducting this survey, decisions regarding whether to reflect opinions shared were made independently by the survey team.
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



